Stockscreener 앱 받기
22.63
3.24%
0.71
전일 마감가:
$21.92
열려 있는:
$22.04
하루 거래량:
22,507
Relative Volume:
0.22
시가총액:
$327.59M
수익:
$1.80M
순이익/손실:
$1.76B
주가수익비율:
0.1907
EPS:
118.674
순현금흐름:
$-149.23M
1주 성능:
+7.86%
1개월 성능:
+3.95%
6개월 성능:
+72.22%
1년 성능:
+100.27%
1일 변동 폭
$22.04
$23.40
1주일 범위
$20.55
$23.40
52주 변동 폭
$10.80
$25.29
인히브릭스 Stock (INBX) Company Profile
명칭
Inhibrx Biosciences Inc
전화
(858) 795-4220
주소
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
INBX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
22.63 | 309.78M | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.65 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.96 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.87 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
645.35 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
302.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
인히브릭스 Stock (INBX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 개시 | JMP Securities | Mkt Perform |
| 2024-01-23 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | 개시 | SMBC Nikko | Outperform |
| 2021-09-21 | 개시 | JMP Securities | Mkt Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-09-14 | 개시 | Credit Suisse | Outperform |
| 2020-09-14 | 개시 | Evercore ISI | Outperform |
모두보기
인히브릭스 주식(INBX)의 최신 뉴스
Sentiment analysis tools applied to Inhibrx Biosciences Inc.Free Weekly Chart Analysis With Entry Advice - Newser
Reversal indicators forming on Inhibrx Biosciences Inc. stockJuly 2025 Sentiment & Accurate Technical Buy Alerts - Newser
Inhibrx Biosciences Inc. stock trend outlook and recovery pathQuarterly Earnings Summary & Reliable Price Breakout Signals - Newser
Inhibrx Biosciences Inc. stock prediction for this weekSector Rotation and Stock Opportunity Analysis - Newser
Is Inhibrx Biosciences Inc. stock ready for a breakoutAI Triggered Buy Zone Forecast System - Newser
Intrinsic Value of Inhibrx Biosciences Inc. Stock: Is It Undervalued or OvervaluedFree Stable Entry High Return Opportunities - Newser
Tools to assess Inhibrx Biosciences Inc.’s risk profileTrade Safety Matrix for Conservative Traders - Newser
How Inhibrx Biosciences Inc. stock performs during market volatilityFree ROI Boosting Trade Opportunity Calendar - Newser
Does Inhibrx Biosciences Inc. qualify in momentum factor screeningFree ROI Driven Equity Selection With Safety - Newser
Visual trend scoring systems applied to Inhibrx Biosciences Inc.Free Sector Rotation Based Trading Opportunities - Newser
Reversal Traders Monitor Inhibrx Biosciences Inc. for EntryReal-Time Market Sentiment Tracking Gains Momentum - metal.it
What makes Inhibrx Biosciences Inc. stock price move sharplyFree Smart Trend Trading with Weekly Signals - Newser
New Product Launches: Will They Boost Inhibrx Biosciences Inc. Stock in 2025Strong Buy Signal Summary with Entry Zone - Newser
What’s the recovery path for long term holders of Inhibrx Biosciences Inc.Buy Signal Forecast With Short-Term Data - Newser
Inhibrx Biosciences Inc expected to post a loss of $2.76 a shareEarnings Preview - TradingView
Inhibrx Biosciences Inc. Stock Fails to Break Resistance Traders ReactTrade Setups With Clear Risk Limits Highlighted - beatles.ru
Inhibrx Biosciences Inc. stock trendline breakdownSwing Trade Watchlist with Entry Zones - Newser
Why Inhibrx Biosciences Inc. stock attracts strong analyst attentionDeep Stock Performance and Volatility Analysis - Newser
Combining price and volume data for Inhibrx Biosciences Inc.Buy and Hold Return Summary with Charts - Newser
Risk adjusted return profile for Inhibrx Biosciences Inc. analyzedPortfolio Positioning Strategy With Timing - Newser
Is Now a Good Time to Reenter Inhibrx Biosciences Inc.ROI Boosting Trade Opportunity Calendar Published - beatles.ru
What are analysts’ price targets for Inhibrx Biosciences Inc. in the next 12 monthsIdentify winners with top-tier analysis - Jammu Links News
Inhibrx Biosciences Inc. Reversal Rally May Surprise BearsExit Ready Momentum Stock Watchlist Expanded - metal.it
Will Inhibrx Biosciences Inc. outperform the marketFree Community Entry Consensus Trade Ideas - Newser
Inhibrx Biosciences Inc. Stock Analysis and ForecastAccelerated capital growth - Jammu Links News
What analysts say about Inhibrx Biosciences Inc. stockGet real-time alerts on high-potential stocks - Jammu Links News
Does Inhibrx Biosciences Inc. stock perform well during market downturnsTriple-digit wealth increases - Jammu Links News
Is Inhibrx Biosciences Inc. stock overvalued or undervaluedAmplify your gains with low-risk picks - Jammu Links News
What moving averages say about Inhibrx Biosciences Inc.2-Day Signal Watch with Forecast Outcome - Newser
Inhibrx Biosciences Inc. Company Revenue and Profit Trends: A Deep DiveWeekly Stock Market Strategy Summary - Newser
What is the risk reward ratio of investing in Inhibrx Biosciences Inc. stockConsistent high-performance stocks - Jammu Links News
What are Inhibrx Biosciences Inc. company’s key revenue driversNavigate market shifts with confidence - Jammu Links News
인히브릭스 (INBX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.83%
자본화:
|
볼륨(24시간):